Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadine Carbuccia

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
American Journal of Hematology|April 27, 2012
Acute myeloid leukemia with myelodysplasia-related changes are characterized by a specific molecular pattern with high frequency of ASXL1 mutationsRaynier Devillier, Véronique Gelsi-Boyer, Mandy Brecqueville, et al.
Leukemia Research|December 22, 2007
Common features of myeloproliferative disorders with t(8;9)(p12;q33) and CEP110-FGFR1 fusion: report of a new case and review of the literatureMarie-Joëlle Mozziconacci, Nadine Carbuccia, Thomas Prebet, et al.
British Journal of Haematology|May 19, 2004
Variant MYST4-CBP gene fusion in a t(10;16) acute myeloid leukaemiaAnne Murati, José Adélaïde, Marie-Joëlle Mozziconacci, et al.
American Journal of Hematology|August 6, 2010
Alteration of cohesin genes in myeloid diseasesJulien Rocquain, Véronique Gelsi-Boyer, José Adélaïde, et al.
Oncology Letters|September 12, 2012
Absence of R140Q mutation of isocitrate dehydrogenase 2 in gliomas and breast cancersStéphane Raynaud, Nadine Carbuccia, Carole Colin, et al.
BMC Cancer|August 4, 2010
Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemiasJulien Rocquain, Nadine Carbuccia, Virginie Trouplin, et al.
Oncotarget|March 31, 2016
Comparative genomic analysis of primary tumors and metastases in breast cancerFrançois Bertucci, Pascal Finetti, Arnaud Guille, et al.
Leukemia Research|November 3, 2009
A gene expression signature of primary resistance to imatinib in chronic myeloid leukemiaHugues de Lavallade, Pascal Finetti, Nadine Carbuccia, et al.
Cancer Genetics and Cytogenetics|June 19, 2007
Rearrangements involving 12q in myeloproliferative disorders: possible role of HMGA2 and SOCS2 genesAnne Etienne, Nadine Carbuccia, José Adélaïde, et al.
Frontiers in Oncology|August 15, 2022
Whole-genome/exome analysis of circulating tumor DNA and comparison to tumor genomics from patients with heavily pre-treated ovarian cancer: subset analysis of the PERMED-01 trialRenaud Sabatier, Séverine Garnier, Arnaud Guille, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
American Journal of Hematology|April 27, 2012
Acute myeloid leukemia with myelodysplasia-related changes are characterized by a specific molecular pattern with high frequency of ASXL1 mutationsRaynier Devillier, Véronique Gelsi-Boyer, Mandy Brecqueville, et al.
Leukemia Research|December 22, 2007
Common features of myeloproliferative disorders with t(8;9)(p12;q33) and CEP110-FGFR1 fusion: report of a new case and review of the literatureMarie-Joëlle Mozziconacci, Nadine Carbuccia, Thomas Prebet, et al.
British Journal of Haematology|May 19, 2004
Variant MYST4-CBP gene fusion in a t(10;16) acute myeloid leukaemiaAnne Murati, José Adélaïde, Marie-Joëlle Mozziconacci, et al.
American Journal of Hematology|August 6, 2010
Alteration of cohesin genes in myeloid diseasesJulien Rocquain, Véronique Gelsi-Boyer, José Adélaïde, et al.
Oncology Letters|September 12, 2012
Absence of R140Q mutation of isocitrate dehydrogenase 2 in gliomas and breast cancersStéphane Raynaud, Nadine Carbuccia, Carole Colin, et al.
BMC Cancer|August 4, 2010
Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemiasJulien Rocquain, Nadine Carbuccia, Virginie Trouplin, et al.
Oncotarget|March 31, 2016
Comparative genomic analysis of primary tumors and metastases in breast cancerFrançois Bertucci, Pascal Finetti, Arnaud Guille, et al.
Leukemia Research|November 3, 2009
A gene expression signature of primary resistance to imatinib in chronic myeloid leukemiaHugues de Lavallade, Pascal Finetti, Nadine Carbuccia, et al.
Cancer Genetics and Cytogenetics|June 19, 2007
Rearrangements involving 12q in myeloproliferative disorders: possible role of HMGA2 and SOCS2 genesAnne Etienne, Nadine Carbuccia, José Adélaïde, et al.
Frontiers in Oncology|August 15, 2022
Whole-genome/exome analysis of circulating tumor DNA and comparison to tumor genomics from patients with heavily pre-treated ovarian cancer: subset analysis of the PERMED-01 trialRenaud Sabatier, Séverine Garnier, Arnaud Guille, et al.
Pageof 4